The Definitive Guide to DuP-697
Other scientific trials in patients with non-Hodgkin's lymphoma [24] and sufferers with State-of-the-art malignancy [fourteen] have shown also that zosuquidar didn't significantly influence the pharmacokinetics of doxorubicin and experienced reasonable consequences over the pharmacokinetics of vincristine. These medical trials approved that zosuqui